Utah Medical Products Retained Earnings (Accumulated Deficit) 2010-2025 | UTMD
Utah Medical Products retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Utah Medical Products Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $129 |
| 2023 | $138 |
| 2022 | $126 |
| 2021 | $115 |
| 2020 | $111 |
| 2019 | $111 |
| 2018 | $100 |
| 2017 | $86 |
| 2016 | $81 |
| 2015 | $73 |
| 2014 | $65 |
| 2013 | $57 |
| 2012 | $50 |
| 2011 | $43 |
| 2010 | $39 |
| 2009 | $39 |
| Utah Medical Products Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $128 |
| 2024-12-31 | $129 |
| 2024-09-30 | $134 |
| 2024-06-30 | $135 |
| 2024-03-31 | $139 |
| 2023-12-31 | $138 |
| 2023-09-30 | $135 |
| 2023-06-30 | $132 |
| 2023-03-31 | $129 |
| 2022-12-31 | $126 |
| 2022-09-30 | $123 |
| 2022-06-30 | $119 |
| 2022-03-31 | $118 |
| 2021-12-31 | $115 |
| 2021-09-30 | $118 |
| 2021-06-30 | $115 |
| 2021-03-31 | $113 |
| 2020-12-31 | $111 |
| 2020-09-30 | $109 |
| 2020-06-30 | $107 |
| 2020-03-31 | $107 |
| 2019-12-31 | $111 |
| 2019-09-30 | $107 |
| 2019-06-30 | $105 |
| 2019-03-31 | $102 |
| 2018-12-31 | $100 |
| 2018-09-30 | $98 |
| 2018-06-30 | $92 |
| 2018-03-31 | $89 |
| 2017-12-31 | $86 |
| 2017-09-30 | $89 |
| 2017-06-30 | $87 |
| 2017-03-31 | $84 |
| 2016-12-31 | $81 |
| 2016-09-30 | $79 |
| 2016-06-30 | $77 |
| 2016-03-31 | $75 |
| 2015-12-31 | $73 |
| 2015-09-30 | $71 |
| 2015-06-30 | $69 |
| 2015-03-31 | $67 |
| 2014-12-31 | $65 |
| 2014-09-30 | $63 |
| 2014-06-30 | $61 |
| 2014-03-31 | $59 |
| 2013-12-31 | $57 |
| 2013-09-30 | $55 |
| 2013-06-30 | $53 |
| 2013-03-31 | $51 |
| 2012-12-31 | $50 |
| 2012-09-30 | $48 |
| 2012-06-30 | $46 |
| 2012-03-31 | $45 |
| 2011-12-31 | $43 |
| 2011-09-30 | $42 |
| 2011-06-30 | $41 |
| 2011-03-31 | $39 |
| 2010-12-31 | $39 |
| 2010-09-30 | $41 |
| 2010-06-30 | $40 |
| 2010-03-31 | $40 |
| 2009-12-31 | $39 |
| 2009-09-30 | $38 |
| 2009-06-30 | $37 |
| 2009-03-31 | $37 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.183B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.716B | 26.12 |
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |